To identify new putative mediators of PT response in EOC cells, we performed an shRNA-based loss-of-function screening to target 680 genes, belonging to apoptosis, TP53 and DNA repair pathways, which play key functions in EOC tumor progression and response to PT-based chemotherapy [17]. The gene discussed is TP53; the disease is neoplasm.